Medicis today announced the launch of its new program, the “Dysport Challenge.” Approved by the U.S. Food and Drug Administration (FDA) in April 2009, Dysport (abobotulinumtoxinA) is a prescription injection used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age.
“We continue to be pleased with the positive feedback from physicians and patients who are using Dysport,” said Jonah Shacknai, chairman and chief executive officer of Medicis. “We are so confident patients will love Dysport that we are introducing the Dysport Challenge. Patients may try Dysport and save $75. If they love it, they may receive $75 off their next Dysport treatment for a total savings of $150. Patients who do not love their Dysport treatment can have their frown lines treated with another botulinum toxin type A product and receive a $75 rebate.”
The Dysport Challenge runs from March 1 through April 30, 2010. Offer terms and conditions apply. For complete offer details, have clients visit www.DysportUSA.com or have them talk to their licensed healthcare professional.